New ADHD drug for kids shows promise in 14-Hour classroom study
Symptom relief
Terminated
This study tests a new medication (CTx-1301) for children aged 6 to 12 with ADHD. The goal is to see if it helps control symptoms like inattention and hyperactivity over a full school day. Children will take the drug or a placebo and be observed in a lab classroom for 14 hours. T…
Phase: PHASE3 • Sponsor: Cingulate Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC